文献速递临床微生物分子诊断

VITEK MITUBE联合MALDI-TOF直接从阳性血培养液鉴定革兰阴性菌的性能首报

First description of the performance of the VITEK MITUBE device used with MALDI-TOF mass spectrometry to achieve identification of gram-negative bacteria directly from positive blood culture broth.
PubMed 文献 · J Clin Microbiol · 2025-07-18

这项多中心研究评估VITEK MITUBE联合MALDI-TOF无需传代直接从阳性血培养液鉴定10种革兰阴性菌的性能。125份前瞻性临床样本中123份(98.4%)准确鉴定,无误鉴定,2份肺炎克雷伯菌未鉴定。结合人工样本,该流程95%情况下可鉴定到种。

要点

  • VITEK MITUBE联合MALDI-TOF可从阳性血培养液直接鉴定革兰阴性菌,无需传代。
  • 125份前瞻性临床样本中98.4%准确鉴定,无误鉴定,1.6%未鉴定。
  • 结合人工样本,该流程鉴定到种的总体比例为95%。

核心结论

  • VITEK MITUBE联合MALDI-TOF流程能够准确可靠地从阳性血培养液中直接鉴定常见革兰阴性菌。

研究设计与样本

  • 多中心研究,用于在欧洲获得体外诊断法规CE认证,评估VITEK MITUBE联合MALDI-TOF直接鉴定性能。
  • 纳入125份前瞻性临床样本,覆盖10种革兰阴性菌,并包含人工样本检测。

主要发现

  • 125份前瞻性临床样本中123份(98.4%)被准确鉴定,无误鉴定,2份(1.6%)肺炎克雷伯菌未鉴定。
  • 结合前瞻性临床样本与人工样本,该流程95%情况下可鉴定到种。
  • 在未能鉴定的样本中,普通变形杆菌占81%(13/16)。
  • 人工样本检测中报告了1例误鉴定错误。

关键数值与推荐

  • 前瞻性临床样本准确鉴定率98.4%(123/125),未鉴定率1.6%(2/125),误鉴定0例。
  • 结合人工样本的总体鉴定到种比例为95%。
  • 未能鉴定样本中普通变形杆菌占81%(13/16)。

临床怎么用

  • 可用于从阳性血培养液直接鉴定常见革兰阴性菌,缩短鉴定时间且无需传代。
  • 对普通变形杆菌等鉴定困难菌种需注意可能出现未鉴定结果。

局限性

  • 前瞻性临床样本仅125份,且部分菌种样本量少。
  • 人工样本检测中出现1例误鉴定错误。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Improving the rapidity of identification of bacteria causing bacteremia continues to be a focus for quality improvement within the discipline of clinical microbiology. This multicenter study was used to obtain In Vitro Diagnostic Regulation Conformite Europeenne (CE) mark in Europe and describes the performance of the VITEK MITUBE to matrix-assisted laser desorption/ionization (MALDI) workflow for identification of 10 species of gram-negative bacteria directly from positive blood culture broth without subculture. One hundred twenty-five (125) prospective clinical samples, including Escherichia coli (69), Klebsiella aerogenes (4), Klebsiella oxytoca (3), Klebsiella pneumoniae (29), Proteus mirabilis (9), Pseudomonas aeruginosa (10), and Serratia marcescens (1), were included; and 123 (98.4%) were accurately identified using the VITEK MITUBE workflow. None were misidentified, and two (1.6%) K. pneumoniae were not identified. Contrived samples were also tested and reported in this study. When considering both the prospective clinical samples and the contrived samples, the workflow was able to identify the species 95% of the time. Proteus vulgaris accounted for 81% (13/16) of the samples that were unable to achieve an identification. A single misidentification error is reported in the contrived sample testing. The VITEK MITUBE to MALDI workflow enables accurate and reliable identification of commonly encountered gram-negative bacteria directly from positive blood culture broth.IMPORTANCEMITUBE is a new in vitro diagnostic device designed to meet a need in the clinical microbiology community for a simple, rapid, accurate, and inexpensive system to identify bacteria detected in blood cultures using MALDI-TOF and without the need for subculture.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Rhoads DD, Hanson ND, Reedy K, et al. First description of the performance of the VITEK MITUBE device used with MALDI-TOF mass spectrometry to achieve identification of gram-negative bacteria directly from positive blood culture broth. J Clin Microbiol. 2025. PMID: 40679847. doi:10.1128/jcm.00122-25

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。